Intracardiac Thrombosis Due to Antiphospholipid Syndrome

Year 2016, Volume: 19 Issue: 3, 201 - 203, 01.12.2016

Nurullah Tüzün Efe Edem , Mustafa Türker Pabuccu

Abstract

Antiphospholipid
syndrome (APS) is an autoimmune disease characterised by arterial and venous
thrombosis. Recurrent thrombosis and pregnancy losses are important in its
diagnosis. Due to the risk of recurrence of thrombosis, long-term anticoagulant
treatment may be required. Here, we present the case of a patient who suffered
from intracardiac thrombosis due to APS. At present, treatment for significant
thrombotic events in patients with APS, such as the aforementioned intracardiac
thrombosis, is generally lifelong. 

Keywords

Antiphospholipid syndrome, intracardiac thrombosis

References

• 1. Soltesz P, Veres K, Lakos G, Kiss E, Muszbek L, Szegedi G. Evaluation of clinical and laboratory features of antiphospholipid syndrome: a restrospective study of 637 patients. Lupus 2003;12:302-7.